Evidence map›Paper›PMID 33314197›Full record

ArticleThe Journal of pathology2021

Alcohol drinking inhibits NOTCH-PAX9 signaling in esophageal squamous epithelial cells.

Menghan Shi, Shuang Ren, Hao Chen, Jing Li, Caizhi Huang, Yahui Li, Yuning Han, Yong Li, Zheng Sun, Xiaoxin Chen and 1 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. PAX9 in Cancer Development.International journal of molecular sciences · 2022
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Menghan ShiBeijing Stomatological Hospital, Capital Medical University, Beijing, PR China.
Shuang RenBeijing Stomatological Hospital, Capital Medical University, Beijing, PR China.
Hao ChenCancer Research Program, Julius L Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC, USA.
Jing LiCancer Research Program, Julius L Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC, USA.
Caizhi HuangCancer Research Program, Julius L Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC, USA.
Yahui LiCancer Research Program, Julius L Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC, USA.
Yuning HanDepartment of Thoracic Surgery, Ningxia Medical University General Hospital, Yinchuan, PR China.
Yong LiDepartment of Thoracic Surgery, National Cancer Center, Cancer Hospital of Chinese Academy of Medical Sciences, Beijing, PR China.
Zheng SunBeijing Stomatological Hospital, Capital Medical University, Beijing, PR China.
Xiaoxin ChenCancer Research Program, Julius L Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC, USA.ORCID 0000-0002-4792-6156
Zhaohui XiongCancer Research Program, Julius L Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC, USA.
North Carolina Central University · USCapital Medical University · CNNingxia Medical University · CNUniversity of North Carolina at Chapel Hill · US

Funding

Understanding Perceptions of HIV Risk, PrEP, and PrEP use among African American Women Attending an HBCUU54MD012392 · NIMHD · NORTH CAROLINA CENTRAL UNIVERSITY · PI Cherise Baldwin Harrington · 2017 to 2026
$38.1M
Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156735 · NCI · NORTH CAROLINA CENTRAL UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 2010 to 2021
$13.0M
RC3 Ethanol-Cannabinoid Interaction in the Regulation of NeurogenesisU54AA019765 · NIAAA · NORTH CAROLINA CENTRAL UNIVERSITY · PI COLE, GREGORY JAY · 2010 to 2019
$8.7M
NOTCH-PAX9 signaling in alcohol-induced esophageal injuryR21AA028047 · NIAAA · NORTH CAROLINA CENTRAL UNIVERSITY · PI CHEN, XIAOXIN LUKE · 2019 to 2020
$389k
Beijing Stomatological Hospital, Capital Medical University YSP202006NCI NIH HHS U54 CA156735NIAAA NIH HHS R21 AA028047NIAAA NIH HHS U54 AA019765NIH HHS R21 AA028047NIH HHS U54 AA019765NIH HHS U54 CA156735NIH HHS U54 MD012392NIMHD NIH HHS U54 MD012392
6 · The paper itself

Abstract

Alcohol drinking has been established as a major risk factor for esophageal diseases. Our previous study showed that ethanol exposure inhibited PAX9 expression in human esophageal squamous epithelial cells in vitro and in vivo. In this study, we aimed to investigate the molecular pathways through which alcohol drinking suppresses PAX9 in esophageal squamous epithelial cells. We first demonstrated the inhibition of NOTCH by ethanol exposure in vitro. NOTCH regulated PAX9 expression in KYSE510 and KYSE410 cells in vitro and in vivo. RBPJ and NOTCH intracellular domain (NIC) D1 ChIP-PCR confirmed Pax9 as a direct downstream target of NOTCH signaling in mouse esophagus. NOTCH inhibition by alcohol drinking was further validated in mouse esophagus and human tissue samples. In conclusion, ethanol exposure inhibited NOTCH signaling and thus suppressed PAX9 expression in esophageal squamous epithelial cells in vitro and in vivo. Our data support a novel mechanism of alcohol-induced esophageal injury through the inhibition of NOTCH-PAX9 signaling. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Indexed as

Alcohol DrinkingAnimalsEpithelial CellsEsophageal Squamous Cell CarcinomaEthanolHumansMicePAX9 Transcription FactorReceptors, NotchSignal TransductionSquamous Cell Carcinoma of Head and NeckEthanolPAX9 Transcription FactorReceptors, Notchesophageal squamous cell carcinomaesophagusethanolNICD1NOTCHPAX9RBPJ

Identifiers

PMID33314197
PMCPMC7987830
OpenAlexW3110761130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.